Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000939
Chunk: 77

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 77
---
 registration (“”),
the Company agrees, at the Company’s sole expense, for as long as the Investor owns Registrable Securities, to use commercially
reasonable efforts to:

a. make
and keep public information available, as those terms are understood and defined in Rule 144;

b. file
with the SEC all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company
remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule
144;

| 9 |

c. furnish
to the Investor so long as the Investor owns Registrable Securities, promptly upon request (i) a written statement by the Company that
it has complied with the reporting and or disclosure provisions of Rule 144(c), the Securities Act and the Exchange Act, (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such
other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration;
and

d. take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the Depositary as may be reasonably requested from time to time by the Investor and otherwise reasonably cooperate with the Investor and the Investor’s broker to effect such sale of securities pursuant to Rule 144; provided, however, the Investor shall provide such documents as may be reasonably required by the Depositary in connection therewith, including any written representations or certifications of the Investor or its broker (which shall not include any opinion of the Investor’s counsel) that may be required by the Depositary in connection therewith.

The Company agrees that damages
may be an inadequate remedy for any breach of the terms and provisions of this and that Investor shall, whether or not
it is pursuing any remedies at law, be entitled to seek equitable relief in the form of a preliminary or permanent injunctions, without
having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.

| 9. | ASSIGNMENT OF REGISTRATION RIGHTS. |

The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor; provided, however, that any transaction, whether by merger, reorganization, restructuring